UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 31, 2023, Shane Barton notified Precision BioSciences, Inc. (the “Company”) of his resignation as the Company’s Vice President and Corporate Controller, effective September 15, 2023, at which time he will cease serving as the principal accounting officer. On September 6, 2023, the Company’s Board of Directors designated Alex Kelly, the Company’s Chief Financial Officer and principal financial officer, to also serve as the Company’s principal accounting officer effective upon Mr. Barton’s departure. Mei Burris, the Company’s Senior Director of Finance and Corporate Controller, will assume responsibilities previously performed by Mr. Barton following his departure.
Mr. Kelly’s biographical information is included in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on March 23, 2023.
Ms. Burris has held roles of increasing responsibility at the Company since February 2019, including most recently Director of Investor Relations and Finance. Prior to this, from August 2017 to February 2019, Ms. Burris served as Assistant Controller of Heat Biologics, Inc. (now Nighthawk Biosciences, Inc.), a publicly traded biotechnology company focused on the discovery and commercialization of innovative medical countermeasures to defend against emerging biothreats. From April 2014 to August 2017, Ms. Burris was with Cempra Pharmaceuticals, Inc. prior to its merger with Melinta Therapeutics, Inc., a publicly traded pharmaceutical company, where Ms. Burris served as Senior Accountant. Ms. Burris is a certified public accountant and earned her Bachelor of Science in Business Administration from West Virginia University.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
PRECISION BIOSCIENCES, INC. |
|
|
|
|
Date: |
September 7, 2023 |
By: |
/s/ Dario Scimeca |
|
|
|
Dario Scimeca |
Document And Entity Information |
Aug. 31, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Aug. 31, 2023 |
Entity Registrant Name | Precision BioSciences, Inc. |
Entity Central Index Key | 0001357874 |
Entity Emerging Growth Company | true |
Securities Act File Number | 001-38841 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 20-4206017 |
Entity Address, Address Line One | 302 East Pettigrew St. |
Entity Address, Address Line Two | Suite A-100 |
Entity Address, City or Town | Durham |
Entity Address, State or Province | NC |
Entity Address, Postal Zip Code | 27701 |
City Area Code | 919 |
Local Phone Number | 314-5512 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Ex Transition Period | false |
Title of 12(b) Security | Common Stock, par value $0.000005 per share |
Trading Symbol | DTIL |
Security Exchange Name | NASDAQ |
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end
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end